146 related articles for article (PubMed ID: 38394046)
1. IL-17A deficiency inhibits lung cancer-induced osteoclastogenesis by promoting apoptosis of osteoclast precursor cells.
Wang H; Tang H; Yuan S; Liang C; Li Y; Zhu S; Chen K
PLoS One; 2024; 19(2):e0299028. PubMed ID: 38394046
[TBL] [Abstract][Full Text] [Related]
2. IL-17A regulates autophagy and promotes osteoclast differentiation through the ERK/mTOR/Beclin1 pathway.
Tang H; Zhu S; Chen K; Yuan S; Hu J; Wang H
PLoS One; 2023; 18(2):e0281845. PubMed ID: 36795736
[TBL] [Abstract][Full Text] [Related]
3. CD147 deficiency blocks IL-8 secretion and inhibits lung cancer-induced osteoclastogenesis.
Wang H; Zhuo Y; Hu X; Shen W; Zhang Y; Chu T
Biochem Biophys Res Commun; 2015 Mar; 458(2):268-73. PubMed ID: 25661002
[TBL] [Abstract][Full Text] [Related]
4. IL-17A modulates osteoclast precursors' apoptosis through autophagy-TRAF3 signaling during osteoclastogenesis.
Xue Y; Liang Z; Fu X; Wang T; Xie Q; Ke D
Biochem Biophys Res Commun; 2019 Jan; 508(4):1088-1092. PubMed ID: 30553450
[TBL] [Abstract][Full Text] [Related]
5. IL-17A regulates the autophagic activity of osteoclast precursors through RANKL-JNK1 signaling during osteoclastogenesis in vitro.
Ke D; Fu X; Xue Y; Wu H; Zhang Y; Chen X; Hou J
Biochem Biophys Res Commun; 2018 Mar; 497(3):890-896. PubMed ID: 29476739
[TBL] [Abstract][Full Text] [Related]
6. Porphyromonas gingivalis-derived lysine gingipain enhances osteoclast differentiation induced by tumor necrosis factor-α and interleukin-1β but suppresses that by interleukin-17A: importance of proteolytic degradation of osteoprotegerin by lysine gingipain.
Akiyama T; Miyamoto Y; Yoshimura K; Yamada A; Takami M; Suzawa T; Hoshino M; Imamura T; Akiyama C; Yasuhara R; Mishima K; Maruyama T; Kohda C; Tanaka K; Potempa J; Yasuda H; Baba K; Kamijo R
J Biol Chem; 2014 May; 289(22):15621-30. PubMed ID: 24755218
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors.
Adamopoulos IE; Chao CC; Geissler R; Laface D; Blumenschein W; Iwakura Y; McClanahan T; Bowman EP
Arthritis Res Ther; 2010; 12(1):R29. PubMed ID: 20167120
[TBL] [Abstract][Full Text] [Related]
8. Different Blood-Borne Human Osteoclast Precursors Respond in Distinct Ways to IL-17A.
Sprangers S; Schoenmaker T; Cao Y; Everts V; de Vries TJ
J Cell Physiol; 2016 Jun; 231(6):1249-60. PubMed ID: 26491867
[TBL] [Abstract][Full Text] [Related]
9. CXCR4 Accelerates Osteoclastogenesis Induced by Non-Small Cell Lung Carcinoma Cells Through Self-Potentiation and VCAM1 Secretion.
Liao T; Chen W; Sun J; Zhang Y; Hu X; Yang S; Qiu H; Li S; Chu T
Cell Physiol Biochem; 2018; 50(3):1084-1099. PubMed ID: 30355915
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase D signaling pathway is involved in lung cancer-derived IL-8 increased osteoclastogenesis.
Hsu YL; Hung JY; Ko YC; Hung CH; Huang MS; Kuo PL
Carcinogenesis; 2010 Apr; 31(4):587-96. PubMed ID: 20106902
[TBL] [Abstract][Full Text] [Related]
11. Shear stress inhibits IL-17A-mediated induction of osteoclastogenesis via osteocyte pathways.
Liao C; Cheng T; Wang S; Zhang C; Jin L; Yang Y
Bone; 2017 Aug; 101():10-20. PubMed ID: 28414140
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis.
Ke D; Yu Y; Li C; Han J; Xu J
Mol Med; 2022 Feb; 28(1):22. PubMed ID: 35183115
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-17 promotes osteoclastogenesis and periodontal damage via autophagy in vitro and in vivo.
Zhong J; Wang Z; Yuan W; Shen Y; Chen L
Int Immunopharmacol; 2022 Jun; 107():108631. PubMed ID: 35219162
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts.
Zhang F; Tanaka H; Kawato T; Kitami S; Nakai K; Motohashi M; Suzuki N; Wang CL; Ochiai K; Isokawa K; Maeno M
Biochimie; 2011 Feb; 93(2):296-305. PubMed ID: 20937352
[TBL] [Abstract][Full Text] [Related]
15. Cyanidin attenuates IL-17A cytokine signaling mediated monocyte migration and differentiation into mature osteoclasts in rheumatoid arthritis.
Samarpita S; Rasool M
Cytokine; 2021 Jun; 142():155502. PubMed ID: 33810944
[TBL] [Abstract][Full Text] [Related]
16. IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells.
Kitami S; Tanaka H; Kawato T; Tanabe N; Katono-Tani T; Zhang F; Suzuki N; Yonehara Y; Maeno M
Biochimie; 2010 Apr; 92(4):398-404. PubMed ID: 20045440
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 19 suppresses RANKL-induced osteoclastogenesis via the inhibition of NF-κB and p38MAPK activation and c-Fos expression in RAW264.7 cells.
Tsubaki M; Takeda T; Matsuda T; Yamamoto Y; Higashinaka A; Yamamoto K; Tsurushima K; Ishizaka T; Nishida S
Cytokine; 2021 Aug; 144():155591. PubMed ID: 34052656
[TBL] [Abstract][Full Text] [Related]
18. Guizhi Shaoyao Zhimu granules attenuate bone destruction in mice with collagen-induced arthritis by promoting mitophagy of osteoclast precursors to inhibit osteoclastogenesis.
Yao H; Xiang L; Huang Y; Tan J; Shen Y; Li F; Geng F; Liu W; Li X; Gao Y
Phytomedicine; 2023 Sep; 118():154967. PubMed ID: 37490802
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-20 differentially regulates bone mesenchymal stem cell activities in RANKL-induced osteoclastogenesis through the OPG/RANKL/RANK axis and the NF-κB, MAPK and AKT signalling pathways.
Meng B; Wu D; Cheng Y; Huang P; Liu Y; Gan L; Liu C; Cao Y
Scand J Immunol; 2020 May; 91(5):e12874. PubMed ID: 32090353
[TBL] [Abstract][Full Text] [Related]
20. Flunarizine inhibits osteoclastogenesis by regulating calcium signaling and promotes osteogenesis.
Kim HJ; Lee J; Lee GR; Kim N; Lee HI; Kwon M; Kim NY; Park JH; Kang YH; Song HJ; Kim T; Shin DM; Jeong W
J Cell Physiol; 2021 Dec; 236(12):8239-8252. PubMed ID: 34192358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
